
|Videos|May 27, 2020
CMSC 2020 Day 1: Brian Weinshenker, MD, on Emerging Treatment Options for NMOSD
Author(s)NeurologyLive® Staff
Brian Weinshenker, MD presents his lecture titled, "Neuromyelitis Optica Spectrum Disorders: Emerging Treatment Options" as part of the 2020 CMSC Virtual Annual Meeting.
Advertisement
For more coverage from CMSC 2020,
To register for the 2020 CMSC Virtual Annual Meeting, May 26-29, 2020,
To complete the evaluation and claim credit, go to
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Phase 1b Trial for Solid Biosciences’ Friedreich Ataxia Gene Therapy SGT-212 Doses First Patient
2
Efficacy and Safety Data for Tavapadon as an Emerging Therapy in Parkinson’s Disease
3
Phase 3 VALOR Data Further Support Tofersen’s Impact on ALS Disease Progression, Survival
4
Efgartigimod Application Submitted for Seronegative gMG, EC Approves High-Dose Nusinersen, Copper Histidinate Gains First Approval for Menkes Disease
5



























